State Street Corporation 13D and 13G filings for Verve Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 07:53 am Sale | 2024-12-31 | 13G | Verve Therapeutics, Inc. VERV | STATE STREET CORP STT | 3,235,747 3.800% | -1,017,470 (-23.92%) | Filing |
| 2024-10-16 1:06 pm Purchase | 2024-09-30 | 13G | Verve Therapeutics, Inc. VERV | STATE STREET CORP STT | 4,253,217 5.000% | 386,453 (+9.99%) | Filing |
| 2024-01-23 10:13 am Sale | 2023-12-31 | 13G | Verve Therapeutics, Inc. VERV | STATE STREET CORP STT | 3,866,764 4.810% | -604,285 (-13.52%) | Filing |
| 2023-02-07 1:11 pm Purchase | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | STATE STREET CORP STT | 4,471,049 7.260% | 4,471,049 (New Position) | Filing |